Long

$KNTE is giving a GREAT IPO LONG opportunity today

Updated
IPO intraday trading strategy idea

Kinnate Biopharma is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers.

The share price is rising and gonna continue this trend today.

The demand for shares of the company still looks higher than the supply.

These and other conditions can cause a rise in the share price today.

So I opened a long position from $42,89;
stop-loss — $39,89;
take-profit — $51,89.

Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.

If you like my content, you can subscribe to the news and receive my fresh ideas.
Trade closed manually
$39,03
intradayIPOipo-stockipo-trademoneysuccessSupply and DemandtraderlifestyleTrend Analysis

More information: fondexx.pro/

!!! Join our trader's chat !!!

Here ==> t.me/fndxworld

We build a cozy community of professional traders
Also on:

Related publications

Disclaimer